Internal Medicine, Pulmonary Disease · Du Bois, PA
NPI
1215105267
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Hospital Ave
Du Bois, PA, 15801
Phone (814) 375-3770
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
2,169 services
Medicare patients, 2024
535
Average age 74
Drug cost, 2024
$3.5M
3,945 prescriptions
Company payments, 2025
$281K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandeep Bansal was code 99214 (office e&m - established), 366 times for 185 patients. In total Sandeep Bansal billed 2,169 services in 43 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 366 | 185 | $88.02 | $32K |
| 99214 Office E&M - Established | Facility | 304 | 171 | $67.42 | $20K |
| 94060 Pulmonary Function Testing | Facility | 206 | 204 | $7.58 | $1,561 |
| 94729 Pulmonary Function Testing | Facility | 158 | 156 | $6.55 | $1,034 |
| 31624 Bronchoscopy | Facility | 121 | 108 | $3.86 | $468 |
| 31652 Bronchoscopy | Facility | 106 | 96 | $103.65 | $11K |
| 94726 Pulmonary Function Testing | Facility | 95 | 95 | $8.84 | $840 |
| 31628 Bronchoscopy | Facility | 82 | 75 | $36.97 | $3,031 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 81 | 17 | $0.09 | $7.28 |
| 31629 Bronchoscopy | Facility | 75 | 69 | $125.28 | $9,396 |
| 31654 Bronchoscopy | Facility | 70 | 64 | $49.90 | $3,493 |
| 31627 Bronchoscopy | Facility | 63 | 58 | $71.80 | $4,523 |
| 94727 Pulmonary Function Testing | Facility | 58 | 56 | $8.94 | $518 |
| 31625 Bronchoscopy | Facility | 34 | 32 | $25.77 | $876 |
| 99204 Office E&M - New | Office | 32 | 32 | $117.36 | $3,756 |
By year: 2022 $118K for 2,250 services; 2023 $143K for 2,736 services; 2024 $117K for 2,169 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandeep Bansal prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 704 prescriptions and refills. In total Sandeep Bansal wrote 3,945 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 704 | 864 | 172 | $537K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 360 | 401 | 135 | $13K |
| Prednisone Generic | 300 | 316 | 169 | $739 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 220 | 260 | 57 | $118K |
| Doxycycline Hyclate Generic | 213 | 217 | 163 | $1,118 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 212 | 246 | 69 | $33K |
| Montelukast Sodium Generic | 173 | 382 | 52 | $2,645 |
| Breo Ellipta Fluticasone/Vilanterol | 170 | 186 | 67 | $72K |
| Dupixent Pen Dupilumab | 151 | 161 | 25 | $607K |
| Fluticasone Propionate Generic | 141 | 177 | 50 | $1,052 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 119 | 135 | 29 | $82K |
| Arnuity Ellipta Fluticasone Furoate | 109 | 117 | 29 | $24K |
| Spiriva Respimat Tiotropium Bromide | 97 | 102 | 37 | $49K |
| Ventolin Hfa Albuterol Sulfate | 64 | 67 | 28 | $3,919 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 59 | 68 | 22 | $12K |
Brand drugs: 2,362 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandeep Bansal $281K ($281K in general payments such as food, travel and fees) from 33 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $109K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 72 | $109K |
| Genzyme Corporation SNY | 34 | $62K |
| Verona Pharma, Inc. VRNA | 28 | $43K |
| AstraZeneca Pharmaceuticals LP AZN | 41 | $28K |
| GlaxoSmithKline, LLC. GSK | 52 | $19K |
| Viatris Specialty LLC | 6 | $8,328 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $6,432 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $2,673 |
| Noah Medical Corporation | 3 | $1,609 |
| Lilly USA, LLC LLY | 3 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.